Characterization of Endoderm Stem Cells Derived from Murine ESCs
Characterization of Endoderm Stem Cells Derived from Murine ESCs
批准号:
7658494
负责人:
Jon S Odorico
金额:
$18.56万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-22 至 2011-03-31
关键词:
AddressAlveolar CellAnimalsBackBeta CellCell Adhesion MoleculesCell LineCell SeparationCellsCharacteristicsCoculture TechniquesCommitCultured CellsDataDerivation procedureDevelopmentES Cell LineEmbryoEndodermEndoderm CellEnvironmentEpithelial CellsEpitheliumGenerationsGenesGerm LayersGlucoseGoalsGrowthGrowth FactorHepatocyteHumanImmunodeficient MouseIn VitroInjection of therapeutic agentInsulinIslets of LangerhansKnowledgeLengthLiverLungMagnetismMorphologyMusNoduleOrganOrgan DonorPancreasPatternPhenotypePopulationPopulation HeterogeneityPrimitive StreaksPrimitive foregut structureProductionProtocols documentationPublishingReplacement TherapySignal TransductionSorting - Cell MovementSourceStem cell transplantStem cellsStructure of beta Cell of isletTeratomaTestingTherapeuticTimeTissuesTo specifyTransplantationUndifferentiatedVisceralbaseblastomere structurecell typeembryonic stem cellimprovedin vivopancreas developmentpublic health relevancesegregationstem cell populationtumorigenic
中文摘要
描述(由申请人提供):胚胎干细胞(ESC)被设想为可移植胰岛的来源,以缓解供体器官短缺。尽管最近取得了许多进展,但将ESC分化为葡萄糖响应性胰岛素分泌β细胞的同质池的方案尚未开发。人们普遍认为,这些种群的产生首先需要产生定形内胚层。因此,内胚层限制性干细胞系的成功衍生和稳定繁殖将是胰腺,肝脏和肺细胞用于细胞替代疗法的发展中的重要一步,并提高了我们对这些组织通常如何从该胚层形成的理解。我们已经开发了一个简单的协议,使用磁激活细胞分选(MACS),分离上皮细胞粘附分子(EpCAM)表达的基础上分化的小鼠胚胎干细胞的异质性培养的内胚层定向细胞。该方案包括去除未分化的ESC和内脏内胚层细胞的阴性选择,以及保留表达EpCAM的细胞的阳性选择。当将分选的细胞置于免疫缺陷小鼠皮下时,发育出高度令人联想到胚胎胰腺上皮的小EpCAM+ PDX 1+结节。来自这些结节的细胞可以在体外广泛繁殖,并具有内胚层干细胞(EndSC)或前肠限制性干细胞(FGSC)群体的预期特征,这取决于体内生长的持续时间。EndSC是OCT 4+,表达一些早期内胚层限制性基因,而FGSC是OCT 4-,高表达Sox 17,Foxa 2和PDX 1。移植回动物体内的EndSC和FGSC重现了原始结节表型,证明了它们在体外的稳定性。我们假设仅从MACS分离回收的OCT 4 +EpCAM+ SSEA 1-细胞产生体内衍生的内胚层细胞系。在这里,我们将通过使用OCT 4GFP ESC系对OCT 4 +EpCAM+ SSEA 1-细胞进行FACS分选来直接测试该假设。将从FACS分选的群体衍生的细胞系与现有的MACS衍生的EndSC和FGSC进行比较。我们还将研究EndSC和FGSC在体外分化为特定内胚层来源的细胞类型(包括β细胞)的能力。为了促进分化,我们将在胚胎胰腺环境中培养细胞,将细胞暴露于相关的生长因子信号,并根据最近公布的方案培养细胞。这些研究不仅有助于提高胚胎干细胞向定形内胚层和胰腺谱系的分化效率,而且有助于更好地理解胚层分离和早期胚胎细胞命运决定。公共卫生相关性:我们的初步研究已经导致从分化的小鼠胚胎干细胞(ESC)的细胞系的发展,似乎是前肠内胚层的承诺。这些细胞系是非致瘤性的,在培养中生长良好,在这里,我们建议阐明这些内胚层细胞系的起源细胞,并探讨其在体外分化为胰腺,肝脏和肺细胞的能力。这些知识将有助于建立用于分离和分化人内胚层定向细胞的方案,以产生用于移植治疗的功能细胞。
英文摘要
DESCRIPTION (provided by applicant): Embryonic stem cells (ESCs) are envisioned as a source of transplantable pancreatic islets to alleviate the donor organ shortage. Despite many recent advances, protocols to differentiate ESCs to homogeneous pools of glucose-responsive insulin-secreting beta cells have yet to be developed. It is widely accepted that the production of these populations will first require generation of definitive endoderm. Thus, the successful derivation and stable propagation of endoderm-restricted stem cell lines would be a significant step forward in the development of pancreas, liver, and lung cells for cell replacement therapies and for improving our understanding of how these tissues are normally formed from this germ layer. We have developed a simple protocol, using magnetic-activated cell sorting (MACS), to isolate endoderm-committed cells from heterogeneous cultures of differentiated murine ESCs on the basis of epithelial cell adhesion molecule (EpCAM) expression. The protocol includes negative selection to remove undifferentiated ESCs and visceral endoderm cells, and positive selection to retain cells that express EpCAM. When sorted cells are placed sub-cutaneously into immunodeficient mice, small EpCAM+PDX1+ nodules highly reminiscent of embryonic pancreatic epithelium develop. Cells from these nodules can be extensively propagated in vitro and have the characteristics expected of an endodermal stem cell (EndSC) or foregut- restricted stem cell (FGSC) population, depending on the duration of growth in vivo. The EndSCs are OCT4+ and express some early endoderm-restricted genes, whereas FGSCs are OCT4- and have high expression of Sox17, Foxa2, and PDX1. EndSCs and FGSCs transplanted back into animals recapitulate the original nodule phenotype, demonstrating their stability in vitro. We hypothesize that only the OCT4+EpCAM+SSEA1- cells recovered from the MACS separation give rise to the in vivo-derived endodermal cell lines. Here, we will directly test this hypothesis by FACS-sorting OCT4+EpCAM+SSEA1- cells using an OCT4GFP ESC line. Cell lines derived from the FACS-sorted population will be compared to the existing MACS-derived EndSCs and FGSCs. We will also study the ability of EndSCs and FGSCs to differentiate in vitro to specific endoderm-derived cell types, including beta cells. To promote differentiation, we will culture cells in an embryonic pancreas environment, expose cells to relevant growth factor signals, and culture cells according to recently published protocols. These studies will contribute not only to improved differentiation efficiency of ESCs to definitive endoderm and pancreatic lineages, but also to a better understanding of germ layer segregation and early embryonic cell fate decisions. PUBLIC HEALTH RELEVANCE: Our preliminary studies have led to the development of cell lines from differentiated mouse embryonic stem cells (ESCs) that appear to be foregut endoderm-committed. These cell lines are non-tumorigenic and grow well in culture, and here we propose to elucidate the cell of origin of these endodermal cell lines and explore their ability to differentiate into pancreatic, liver, and lung cells in vitro. This knowledge will help in establishing protocols for the isolation and differentiation of human endoderm-committed cells for the production of functional cells to be used in transplantation therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transformational platform for regenerating autologous transplantable endocrine tissue from human pancreatic matrix and pluripotent stem cells
-
批准号:9169474
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2016
-
负责人:Jon S Odorico
-
依托单位:
Transformational platform for regenerating autologous transplantable endocrine tissue from human pancreatic matrix and pluripotent stem cells
-
批准号:9307694
-
项目类别:
-
资助金额:$18.49万
-
财政年份:2016
-
负责人:Jon S Odorico
-
依托单位:
ISLET TRANSPLANTATION IN TYPE 1 DIABETES USING STEROID-FREE IMMUNOSUPPRESSION
-
批准号:7204338
-
项目类别:
-
资助金额:$1.09万
-
财政年份:2005
-
负责人:Jon S Odorico
-
依托单位:
PANCREATIC ISLET DIFFERENTIATION FROM RHESUS ES CELLS AND TRANSPLANTATION
-
批准号:7165675
-
项目类别:
-
资助金额:$3.48万
-
财政年份:2005
-
负责人:Jon S Odorico
-
依托单位:
PANCREATIC ISLET DIFFERENTIATION FROM RHESUS ES CELLS
-
批准号:6971232
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2004
-
负责人:Jon S Odorico
-
依托单位:
Islet Transplantation in Type 1 Diabetes Using Steroid-Free Immunosuppression
-
批准号:7043884
-
项目类别:
-
资助金额:$2.31万
-
财政年份:2003
-
负责人:Jon S Odorico
-
依托单位:
RHESUS ES CELLS: A MODEL TO STUDY PANCREAS DEVELOPMENT
-
批准号:6381948
-
项目类别:
-
资助金额:$14.4万
-
财政年份:2000
-
负责人:Jon S Odorico
-
依托单位:
RHESUS ES CELLS: A MODEL TO STUDY PANCREAS DEVELOPMENT
-
批准号:6089128
-
项目类别:
-
资助金额:$14.4万
-
财政年份:2000
-
负责人:Jon S Odorico
-
依托单位:
海外基金